Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases

…, PB Vermeulen, S Foo, E Kostaras, MR Nathan… - Nature medicine, 2016 - nature.com
The efficacy of angiogenesis inhibitors in cancer is limited by resistance mechanisms that
are poorly understood. Notably, instead of through the induction of angiogenesis, tumor …

Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis

S Gangi, JG Fletcher, MA Nathan… - American Journal of …, 2004 - Am Roentgen Ray Soc
OBJECTIVE. Our purpose was to determine whether abdominal CT can detect pancreatic
cancer before its clinical diagnosis. SUBJECTS AND METHODS. Two radiologists interpreted …

Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil

K Kitajima, RC Murphy, MA Nathan… - Journal of Nuclear …, 2014 - Soc Nuclear Med
The aim of this study was to compare 11 C-choline PET/CT with pelvic multiparametric MR
imaging for detection of recurrent prostate carcinoma in patients with suspected recurrence …

Vessel co‐option is common in human lung metastases and mediates resistance to anti‐angiogenic therapy in preclinical lung metastasis models

…, F Daley, E Kostaras, MR Nathan… - The Journal of …, 2017 - Wiley Online Library
Anti‐angiogenic therapies have shown limited efficacy in the clinical management of metastatic
disease, including lung metastases. Moreover, the mechanisms via which tumours resist …

Characterization of the Solitary Pulmonary Nodule: 18F-FDG PET Versus Nodule-Enhancement CT

JA Christensen, MA Nathan… - American Journal of …, 2006 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study was to directly compare nodule-enhancement CT
and 18 F-FDG PET in the characterization of indeterminate solitary pulmonary nodules (SPNs) …

[HTML][HTML] A review of fulvestrant in breast cancer

MR Nathan, P Schmid - Oncology and therapy, 2017 - Springer
Fulvestrant is a selective estrogen receptor degrader that binds, blocks and degrades the
estrogen receptor (ER), leading to complete inhibition of estrogen signaling through the ER. …

Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland

…, RM Subramaniam, MA Nathan… - Journal of Nuclear …, 2007 - Soc Nuclear Med
Our purpose was to determine the clinical significance of diffusely increased 18 F-FDG uptake
in the thyroid gland as an incidental finding on PET/CT. Methods: All patients who were …

Differentiation of nonperforated from perforated appendicitis: accuracy of CT diagnosis and relationship of CT findings to length of hospital stay

TA Foley, F Earnest IV, MA Nathan, DM Hough… - Radiology, 2005 - pubs.rsna.org
PURPOSE: To determine retrospectively the sensitivity and specificity of computed
tomographic (CT) signs in differentiating acute nonperforated appendicitis from perforated …

The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET–CT

TV Bogsrud, D Karantanis, MA Nathan… - Nuclear medicine …, 2007 - journals.lww.com
Objective To determine if quantification of [18 F] fluorodeoxyglucose (18 F-FDG) uptake in a
thyroid nodule found incidentally on whole-body 18 F-FDG positron emission tomography–…

Evaluation of 18F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors

SM Broski, GB Johnson, BM Howe, MA Nathan… - Skeletal Radiology, 2016 - Springer
Objective To compare 18F-FDG PET/CT and MRI for differentiating benign and malignant
peripheral nerve sheath tumors (BPNSTs and MPNSTs) and correlate imaging characteristics …